BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Job Trends

  Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI

  A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing and adopting AI, including their increased use of external help with the process.

  July 31, 2025

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Job Trends

  7 Companies Hiring in North Carolina

  Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences professionals like you.

  July 31, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Alzheimer’s disease

  Amyloid Return ‘Slow’ After Stopping Lilly’s Kisunla

  Long-term extension data presented at the Alzheimer’s Association International Conference showed amyloid plaque reaccumulation remained slow at up to 2.5 years of follow-up in patients who were taken off of treatment with Eli Lilly’s anti-amyloid antibody.

  July 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Immunology and inflammation

  AbbVie Carves Out Niche for Rinvoq With ‘Impressive’ Alopecia Areata Data

  Rinvoq’s efficacy in alopecia areata is “impressive,” according to Guggenheim analysts, who said the drug could have a competitive edge over other JAK inhibitors in the space.

  July 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IN PARTNERSHIP WITH IQVIA

  We Don’t Own Patient Data–We’re Just Babysitting It

  In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.

  July 31, 2025

   · 

  1 min read

   · 

  Lori Ellis
• 

  Diabetes

  Lilly’s Mounjaro ‘Good Enough’ in Cardio Trial, Will Seek Expanded Approval

  While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical significance in reducing major events such as cardiovascular death, heart attack and stroke.

  July 31, 2025

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Layoffs

  Moderna Slashes Global Workforce by 10% as $1.5B Cost Cuts Hit Home

  The announced reduction of hundreds of staff came a day ahead of Moderna’s Q2 earnings report.

  July 31, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Earnings

  Biogen’s Leqembi Push Getting Easier as CEO Eyes Early-Stage Pipeline Restock

  Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter earnings call. The partnered Alzheimer’s drug Leqembi saw sales climb 20% for the period.

  July 31, 2025

   · 

  4 min read

   · 

  Annalee Armstrong
• 

  Job Trends

  Greener Pastures? 81% of Employed Biopharma Professionals Want New Jobs, BioSpace Finds

  Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely as their unemployed counterparts, according to a BioSpace LinkedIn poll. Three recruitment experts discuss the findings and what’s driving job searches.

  July 31, 2025

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Earnings

  Sanofi Confident Tariffs Will Have Limited Impact on Finances in 2025

  For now, Sanofi’s U.S. inventory is insulating the company from a potential 15% tariff on drugs shipped from the EU.

  July 31, 2025

   · 

  2 min read

   · 

  Nick Paul Taylor